KMDA Q2 2024 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena

KMDAKamada Ltd.

$520M

Q2 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$42M+13.4% YoY

Gross Profit

$19M44.6% margin

Operating Income

$6M13.3% margin

Net Income

$4M10.4% margin

EPS (Diluted)

$0.08

QoQ Revenue Growth

+12.6%

Cash Flow

Operating Cash Flow

$14M

Free Cash Flow

$11M

Stock-Based Comp.

$235,000

Balance Sheet

Total Assets

$351M

Total Liabilities

$100M

Stockholders' Equity

$251M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$42M	$37M	+13.4%
Gross Profit	$19M	$14M	+31.3%
Operating Income	$6M	$3M	+114.4%
Net Income	$4M	$2M	+144.3%